By contrast, the therapeutic use of the anti-progesterone mifepristone (RU-486), which in animal experiments also potently prevents tumour development in Brca1;p53;WapCCre mice [74], is limited due to toxicity. The gene discussed is BRCA1; the disease is neoplasm.